Hilde Johanna van der Kamp

Insider Reports History

Entity
Individual
Location
C/O Newamsterdam Pharma Company N.V., Gooimeer 2 35, Naarden, Netherlands
Signature
/s/ Louise Kooij by Power of Attorney from Hilde Johanna van der Kamp
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hilde Johanna van der Kamp:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 6.96K $178K $25.54 Jan 7, 2025 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 32.5K Jan 6, 2025 Direct

Insider Reports Filed by Hilde Johanna van der Kamp

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAMS NewAmsterdam Pharma Co N.V. Jan 6, 2025 2 $0 4 Jan 8, 2025 Director
NAMS NewAmsterdam Pharma Co N.V. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3 Dec 29, 2023 Director